The World Health Organization and US Centers for Disease Control and Prevention recommend that both infected and susceptible people wear face masks to protect against COVID-19.
Methods
We develop a dynamic disease model to assess the effectiveness of face masks in reducing the spread of COVID-19, during an initial outbreak and a later resurgence, as a function of mask effectiveness, coverage, intervention timing, and time horizon. We instantiate the model for the COVID-19 outbreak in New York, with sensitivity analyses on key natural history parameters.
Results
During the initial epidemic outbreak, with no social distancing, only 100% coverage of masks with high effectiveness can reduce the effective reproductive number below 1. During a resurgence, with lowered transmission rates due to social distancing measures, masks with medium effectiveness at 80% coverage can reduce below 1 but cannot do so if individuals relax social distancing efforts. Full mask coverage could significantly improve outcomes during a resurgence: with social distancing, masks with at least medium effectiveness could reduce below 1 and avert almost all infections, even with intervention fatigue. For coverage levels below 100%, prioritizing masks that reduce the risk of an infected individual from spreading the infection rather than the risk of a susceptible individual from getting infected yields the greatest benefit.
Limitations
Data regarding COVID-19 transmission are uncertain, and empirical evidence on mask effectiveness is limited. Our analyses assume homogeneous mixing, providing an upper bound on mask effectiveness.
Conclusions
Even moderately effective face masks can play a role in reducing the spread of COVID-19, particularly with full coverage, but should be combined with social distancing measures to reduce below 1.
Highlights
We develop a model to assess the effectiveness of face masks in reducing the spread of COVID-19.
For coverage levels below 100%, prioritizing masks that reduce the risk of an infected individual from spreading the infection rather than the risk of a susceptible individual from getting infected yields the greatest benefit.
Even moderately effective face masks can play a role in reducing the spread of COVID-19, particularly with full coverage, but should be combined with social distancing measures to reduce the effective reproductive number below 1.
John Hopkins University Coronavirus Resource Center. COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). 2020. Available from: https://coronavirus.jhu.edu/map.html
Centers for Disease Control and Prevention. Interim recommendations for face-mask and respirator use to reduce 2009 influenza A (H1N1) virus transmission. 2009. Available from: https://www.cdc.gov/h1n1flu/masks.htm
8.
TrachtSMDel ValleSYHymanJM.Mathematical modeling of the effectiveness of facemasks in reducing the spread of novel influenza A (H1N1). PLoS One. 2010;5(2):e9018.
9.
TrachtSMDel ValleSYEdwardsBK.Economic analysis of the use of facemasks during pandemic (H1N1) 2009. J Theor Biol. 2012;300:161–72.
10.
BrienenNCJTimenAWallingaJVan SteenbergenJETeunisPFM. The effect of mask use on the spread of influenza during a pandemic. Risk Anal. 2010;30(8):1210–8.
11.
ChengVCCWongSCChuangVWM, et al. The role of community-wide wearing of face mask for control of coronavirus disease 2019 (COVID-19) epidemic due to SARS-CoV-2. J Infect. 2020;81(1):107–14.
12.
LyuWWehbyGL.Community use of face masks and COVID-19: evidence from a natural experiment of state mandates in the US. Health Aff (Millwood). 2020;39(8):1419–25.
13.
ChuDKAklEADudaS, et al. Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis. Lancet. 2020;395(10242):1973–87.
14.
WangYTianHZhangL, et al. Reduction of secondary transmission of SARS-CoV-2 in households by face mask use, disinfection and social distancing: a cohort study in Beijing, China. BMJ Glob Health. 2020;5(5):e002794.
15.
BundgaardHBundgaardJSRaaschou-PedersenDET, et al. Effectiveness of adding a mask recommendation to other public health measures to prevent SARS-CoV-2 infection in Danish mask wearers. Ann Intern Med. 2021;174(3):335–343.
16.
MacIntyreCRZhangYChughtaiAA, et al. Cluster randomised controlled trial to examine medical mask use as source control for people with respiratory illness. BMJ Open. 2016;6(12):e012330.
17.
CowlingBJChanKHFangVJ, et al. Facemasks and hand hygiene to prevent influenza transmission in households: a cluster randomized trial. Ann Intern Med. 2009;151(7):437–46.
18.
SuessTRemschmidtCSchinkSB, et al. The role of facemasks and hand hygiene in the prevention of influenza transmission in households: results from a cluster randomised trial; Berlin, Germany, 2009-2011. BMC Infect Dis. 2012;12(1):26.
19.
ClappPWSickbert-BennettEESametJM, et al. Evaluation of cloth masks and modified procedure masks as personal protective equipment for the public during the COVID-19 pandemic. JAMA Intern Med. 2021;181(4):463–9.
20.
CumboEScardinaGA.Management and use of filter masks in the “none-medical” population during the COVID-19 period. Safety Sci. 2021;133:104997.
21.
ChuaMHChengWGohSS, et al. Face masks in the new COVID-19 normal: materials, testing, and perspectives. Research (Wash D C). 2020;2020:7286735.
22.
EikenberrySEMancusoMIboiE, et al. To mask or not to mask: modeling the potential for face mask use by the general public to curtail the COVID-19 pandemic. Infect Dis Model. 2020;5:293–308.
23.
LiTLiuYLiMQianXDaiSY.Mask or no mask for COVID-19: a public health and market study. PLoS One. 2020;15(8):1–17.
24.
NgonghalaCNIboiEEikenberryS, et al. Mathematical assessment of the impact of non-pharmaceutical interventions on curtailing the 2019 novel coronavirus. Math Biosci. 2020;325:108364.
25.
NgonghalaCNIboiEAGumelAB.Could masks curtail the post-lockdown resurgence of COVID-19 in the US?Math Biosci. 2020;329:108452.
26.
StuttROJHRetkuteRBradleyMGilliganCAColvinJ. A modelling framework to assess the likely effectiveness of facemasks in combination with ‘lockdown’ in managing the COVID-19 pandemic. Proc R Soc A. 2020;476:20200376.
27.
KeelingMJRohaniP.Modeling Infectious Diseases in Humans and Animals. Princeton (NJ): Princeton University Press; 2008.
28.
LiRPeiSChenB, et al. Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2). Science. 2020;368(6490):489–93.
29.
DuZWangLCauchemezS, et al. Risk for transportation of coronavirus disease from Wuhan to other cities in China. Emerg Infect Dis. 2020;26(5):1049–52.
30.
MunsterVJKoopmansMvan DoremalenNvan RielDde WitE.A novel coronavirus emerging in China—key questions for impact assessment. N Engl J Med. 2020;382(8):692–4.
31.
YouCDengYHuW, et al. Estimation of the time-varying reproduction number of COVID-19 outbreak in China. Int J Hyg Environ Health. 2020;228:113555.
32.
HeffernanJSmithRWahlL.Perspectives on the basic reproductive ratio. J R Soc Interface. 2005;2(4):281–93.
33.
DiekmannOHeesterbeekJAPMetzJAJ. On the definition and the computation of the basic reproduction ratio R0 in models for infectious diseases in heterogeneous populations. J Math Biol. 1990;28:365–82.
34.
New York Times. Data from The New York Times, based on reports from state and local health agencies. 2020. Available from: https://github.com/nytimes/covid-19-data
BiQWuYMeiS, et al. Epidemiology and transmission of COVID-19 in Shenzhen China: analysis of 391 cases and 1,286 of their close contacts. Lancet Infect Dis. 2020;20(8):P911–9.
37.
LauerSAGrantzKHBiQ, et al. The incubation period of COVID-19 from publicly reported confirmed cases: estimation and application. Ann Intern Med. 2020;172(9):577–82.
ZhouFYuTDuR, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(102229):1054–62.
40.
WuZMcGooganJM.Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72,314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239–42.
41.
LevinATHanageWPOwusu-BoaiteyNCochranKBWalshSPMeyerowitz-KatzG.Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications. Eur J Epidemiol. 2020;35:1123–38.
42.
SuttonDFuchsKD’AltonMGoffmanD.Universal screening for SARS-CoV-2 in women admitted for delivery. N Engl J Med. 2020;382(22):2163–4.
MckayMDBeckmanRJConoverWJ.A comparison of three methods for selecting values of input variables in the analysis of output from a computer code. Technometrics. 2000;42(1):55–61.
45.
SancheSLinYTXuCRomero-SeversonEHengartnerNKeR.High contagiousness and rapid spread of severe acute respiratory syndrome coronavirus 2. Emerg Infect Dis. 2020;26(7):1470–7.
TangBWangXLiQ, et al. Estimation of the transmission risk of the 2019-nCoV and its implication for public health interventions. J Clin Med. 2020;9(2):462.
48.
TangJLiebnerTCravenBSettlesG.A schlieren optical study of the human cough with and without wearing masks for aerosol infection control. J R Soc Interface. 2009;6(suppl 6):S727–36.
49.
MoghadasSMShoukatAFitzpatrickMC, et al. Projecting hospital utilization during the COVID-19 outbreaks in the United States. Proc Natl Acad Sci. 2020;117(16):9122–6.
WangXPascoRFDuZ, et al. Impact of social distancing measures on coronavirus disease healthcare demand, Central Texas, USA. Emerg Infect Dis. 2020;26(10):2361–9.
ZhaoJLeeMGhaderS, et al. Quarantine fatigue: first-ever decrease in social distancing measures after the COVID-19 outbreak before reopening United States. 2020. Available from: https://arxiv.org/abs/2006.03716
59.
ShaverK.‘Quarantine fatigue’ continues for second week, showing a worrisome trend, researchers say. Washington Post. April28, 2020.
60.
RypdalKBianchiFMRypdalM.Intervention fatigue is the primary cause of strong secondary waves in the COVID-19 pandemic. Int J Environ Res Public Health. 2020;17(24):9592.
61.
O’GradyS.Unlike the United States, more and more countries are making masks mandatory. Washington Post. July20, 2020.
62.
WhitmerG.What if Trump made everyone wear masks?New York Times. July22, 2020.
63.
BetschCKornLSprengholzP, et al. Social and behavioral consequences of mask policies during the COVID-19 pandemic. Proc Natl Acad Sci U S A. 2020;117(36):21851–3.
64.
HaischerMHBeilfussRHartMR, et al. Who is wearing a mask? Gender-, age-, and location-related differences during the COVID-19 pandemic. PLoS One. 2020;15(10):1–12.
WeinbergerDMChenJCohenT, et al. Estimation of excess deaths associated with the COVID-19 pandemic in the United States, March to May 2020. JAMA Intern Med. 2020;180(10):1336–44.
67.
KirkcaldyRDKingBABrooksJT.COVID-19 and postinfection immunity: limited evidence, many remaining questions. JAMA. 2020;323(22):2245–6.
68.
WuLPWangNCChangYH, et al. Duration of antibody responses after severe acute respiratory syndrome. Emerg Infect Dis. 2007;13(10):1562–4.
69.
Abou-IsmailA.Compartmental models of the COVID-19 pandemic for physicians and physician-scientists. SN Compr Clin Med. 2020:1–7.
70.
CooperIMondalAAntonopoulosCG.A SIR model assumption for the spread of COVID-19 in different communities. Chaos Soliton Fract. 2020;139:110057.
71.
RadulescuAWilliamsCCavanaghK.Management strategies in a SEIR-type model of COVID 19 community spread. Sci Rep. 2020;10(1):21256.
MervoshSFernandezM.Months into virus crisis, U.S. cities still lack testing capacity. New York Times. July6, 2020.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
